Anti-CXCL12/SDF-1 Spiegelmer® Nox-A12 Alone and In Combination With Bortezomib and Dexamethasone In Patients With Relapsed Multiple Myeloma: Results From A Phase IIa Study
Title:
Anti-CXCL12/SDF-1 Spiegelmer® Nox-A12 Alone and In Combination With Bortezomib and Dexamethasone In Patients With Relapsed Multiple Myeloma: Results From A Phase IIa Study
Author:
Ludwig, Heinz Weisel, Katja Engelhardt, Monika Greil, Richard Cafro, Anna Maria Petrucci, Maria Teresa Dümmler, Thomas Zöllner, Stefan Zeitler, Stefan Riecke, Kai Kruschinski, Anna